BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Earlybird Venture Capital at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Earlybird Venture Capital takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover the state of early-stage biotech investment and how AI and digital collaboration are changing drug discovery. The investment session is shared with the European Innovation Council, Eir Ventures and Sofinnova Partners.

OrganizationBIO-Europe 2026 Attendance
Investors & finance
European venture capital firm investing in technology and health companies.
Panel
Mon Nov 9
16:00–16:45
Fuelling Innovation: The State of Early-Stage Investment in Biotech
Investors and founders discuss how young biotech startups raise early funding today and how venture investors' priorities are shifting.
with European Innovation Council, Eir Ventures, High-Tech Gründerfonds +2 more
Panel
Wed Nov 11
11:00–11:45
AI-Powered Ecosystems: Transforming Drug Discovery Through Digital Collaboration
How drug, biotech and tech companies can build AI partnerships, and why AI finds easier wins in early discovery than in later clinical stages.
with 59 North Communications, OKG Capital, endogene.bio +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Earlybird Venture Capital

Tell us what you sell and we’ll find the people at Earlybird Venture Capital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction